East Point Bio Strategy

Scientific progress does not determine success.
Commercial decisions do.

Assets advance without clear differentiation.
Indications are pursued without prioritization.
Launch strategies are built without validated adoption logic.

Where we focus:

• Portfolio and indication strategy 
• Differentiation and positioning 
• Go-to-market strategy 

Outcome:
Stronger positioning. Higher probability of success.

Discuss a Strategic Inflection Point